Biotech entity
All 1 tracked stories fall under one category: funding. Of the tracked stories, 1 of 1 also mention AI-native software, the most common co-covered peer. Sean Duffy appears in 1 tracked Biotech story from August 14, 2026. The tracked stories average 2 original sources each.
Last mentioned: Aug 14, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: funding. Of the tracked stories, 1 of 1 also mention AI-native software, the most common co-covered peer. Sean Duffy appears in 1 tracked Biotech story from August 14, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 4 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Sean Duffy. Shared-story counts are live from our verified record — not editorial picks.
Nutex Health delivered a $65.8M Q2 profit despite a 13.6% revenue decline, while Omada Health grew revenue 43% on GLP-1 Care Track demand and raised full-year guidance. For biopharma and healthcare investors, the cluster highlights how care-delivery economics and cardiometabolic programs are reshaping non-drug revenue models.
Sean Duffy is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
